CD8A and colorectal cancer: Mlecnik et al. [27] concluded that the TB-score, which is based on the assessment of CD8+ T-cells and CD20+ B-cells, along with Immunoscore in liver metastases of colorectal cancer were the strongest predictors of DFS and OS.